← Back to Clinical Trials
Recruiting NCT07524192

NCT07524192 A Self-Instructional Online Program for Early Childhood and Elementary Teachers Supporting Autistic Children and Children With Developmental Delays

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07524192
Status Recruiting
Phase
Sponsor Boin Choi
Condition Autism Spectrum Disorder
Study Type INTERVENTIONAL
Enrollment 70 participants
Start Date 2026-02-05
Primary Completion 2026-09-30

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
SEED Online Self-Instructional ProgramComparison Educational Materials (Kit for Kids)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 70 participants in total. It began in 2026-02-05 with a primary completion date of 2026-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to evaluate the preliminary effectiveness and acceptability of a self-instructional, web-based teacher training program designed to support the development of autistic children and children with developmental delays. This study aims to examine whether participation in the program can improve teachers' knowledge, attitudes, and teaching self-efficacy related to inclusive education and support for autistic children and children with developmental delays. The main questions it aims to answer are: 1. Does participation in the self-instructional program improve teachers' knowledge about autism and developmental delays? 2. Does the program improve teachers' attitudes toward inclusive education and their teaching self-efficacy? Researchers will compare teachers who participate in the self-instructional online intervention program (SEED program) with teachers who receive comparison educational materials (Kit for Kids from Organization for Autism Research) to determine whether the intervention leads to greater improvements in knowledge, attitudes, and teaching self-efficacy. Participants will: 1. Complete an online pre-intervention survey assessing background information, knowledge, attitudes toward inclusion and neurodiversity, and teaching self-efficacy. 2. Participate in a two-week self-instructional online program or receive comparison materials, depending on group assignment 3. Complete an online post-intervention survey evaluating the same outcomes, as well as program satisfaction and acceptability.

Eligibility Criteria

Inclusion Criteria: * Public school teachers currently employed in kindergarten or elementary schools who hold at least a Level 2 teaching certificate (or higher). * Teachers who understand the purpose of the study and provide informed consent to participate. Exclusion Criteria: * Teachers who have majored in special education at the undergraduate or graduate level.

Contact & Investigator

Central Contact

Boin Choi

✉ boinchoi@ewha.ac.kr

📞 +82-10-5077-0345

Frequently Asked Questions

Who can join the NCT07524192 clinical trial?

This trial is open to participants of all sexes, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07524192 currently recruiting?

Yes, NCT07524192 is actively recruiting participants. Contact the research team at boinchoi@ewha.ac.kr for enrollment information.

Where is the NCT07524192 trial being conducted?

This trial is being conducted at Seoul, South Korea.

Who is sponsoring the NCT07524192 clinical trial?

NCT07524192 is sponsored by Boin Choi. The trial plans to enroll 70 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology